VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 17:43:02 GMT 2025` Edited by `admin` on `Tue Apr 01 17:43:02 GMT 2025`
Protein Type	RECEPTOR
Protein Sub Type	TYROSINE PROTEIN KINASE
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	8FO9RM2OXK
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3

Common Name

English

FLT-4

Preferred Name

English

FMS-LIKE TYROSINE KINASE 4

Common Name

English

TYROSINE-PROTEIN KINASE RECEPTOR FLT4

Common Name

English

VEGFR3

Common Name

English

Code System Code Type Description

FDA UNII

8FO9RM2OXK

Created by admin on Tue Apr 01 17:43:02 GMT 2025 , Edited by admin on Tue Apr 01 17:43:02 GMT 2025

PRIMARY

UNIPROT

P35916

Created by admin on Tue Apr 01 17:43:02 GMT 2025 , Edited by admin on Tue Apr 01 17:43:02 GMT 2025

PRIMARY

From	To
1_27	1_87
1_134	1_182
1_228	1_286
1_421	1_510
1_554	1_629
1_675	1_727

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_9
N	1_80
N	1_142
N	1_227
N	1_275
N	1_387
N	1_491
N	1_503
N	1_570
N	1_659
N	1_666
N	1_734

Related Record Type Details


					CEGM9YBNGD

Selpercatinib

INHIBITOR -> TARGET


					172030934T

TIVOZANIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					NQU9IPY4K9

CEDIRANIB

INHIBITOR -> TARGET


					Y7HJ4D4CRT

ODM-203

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					C9LVQ0YUXG

Axitinib

INHIBITOR -> TARGET


					49DXG3M5ZW

FRUQUINTINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					F40IRN5981

Ibcasertib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					1C39JW444G

Cabozantinib

INHIBITOR -> TARGET

Amount:


					PP449XA4BH

LUCITANIB

INHIBITOR -> TARGET

Amount:


					V99T50803M

SUNITINIB

INHIBITOR -> TARGET


					9ZOQ3TZI87

SORAFENIB

INHIBITOR -> TARGET


					B2K5L1L8S9

SURUFATINIB

INHIBITOR -> TARGET

Amount:


					VKU5X213Q7

BMS-690514

INHIBITOR -> TARGET


					G6HRD2P839

Nintedanib

INHIBITOR -> TARGET


					18P7197Q7J

TELATINIB

INHIBITOR -> TARGET

Amount:


					GKF8S4C432

Catequentinib

INHIBITOR -> TARGET

Amount:


					7Q29OXD98N

GLESATINIB

INHIBITOR -> TARGET

Structural Modifications

Modification Type	Location Site	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_1044] [1_1206] [1_1207] [1_1241] [1_1339]	TYROSINE O-PHOSPHATE	2R86C98KDX
AMINO ACID SUBSTITUTION	[1_1039] [1_1309] [1_1313]	TYROSINE O-PHOSPHATE	2R86C98KDX
AMINO ACID SUBSTITUTION	[1_806] [1_809] [1_829]	TYROSINE O-PHOSPHATE	2R86C98KDX

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL